Press Releases for ANX

Press Releases
PicksThatMove.com Announces Investment Opinion on China Media Group Corp., Advanced Cell Technology Inc. and Adventrix Pharmaceuticals Inc.
PicksThatMove.com Announces Investment Opinion on Iteration Energy, IBC Advanced Alloys Corp., Xoma Ltd., Adventrix Pharmaceuticals Inc. and Bonanza Oil & Gas Inc.
PicksThatMove.com Announces Investment Opinion on Pacific Ethanol Inc., Eastern Platinum Limited, Adventrix Pharmaceuticals Inc., Advaxis Inc. and Afri-Can Marine Minerals Corporation
Benchmark Journal Offers Fundamental Analysis of Companies in the Financial, Services and Basic Materials Sectors
ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results
ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results ; Conference Call Begins at 4:30 P.M. Eastern Time Today
ADVENTRX Pharmaceuticals Announces Closing of Financing
ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12
ADVENTRX Pharmaceuticals Announces Financing
ADVENTRX Narrows Prior Guidance on NDA Submission Timeline
ADVENTRX Announces Acceptance of Compliance Plan By NYSE AMEX
StreetInvesting.Com Free Research on ANX, SPF, CCC, DNN, SY and SBIB
ADVENTRX Pharmaceuticals Announces Closing of Financing
ADVENTRX Pharmaceuticals Announces Closing of Financing
ADVENTRX Pharmaceuticals Announces Financing
ADVENTRX Pharmaceuticals Announces Financing
ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009
ADVENTRX Pharmaceuticals Announces Closing of Financing
ADVENTRX Pharmaceuticals Announces Financing
ADVENTRX Receives Notice From NYSE Amex
ADVENTRX Pharmaceuticals Reports First Quarter 2009 Financial Results
MaybachFinancial.Com Posts Free Analyst Report on ANX, CX, DCT and GLD
ADVENTRX Announces Results From ANX-514 Bioequivalence Study
ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
ADVENTRX Announces Further Cost-Cutting Measures - Mar 20 2009 4:18PM
ADVENTRX Provides Update on Strategic Transaction Process
ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
ADVENTRX Announces Further Cost-Cutting Measures - Jan 5 2009 6:28PM
ADVENTRX Exploring Strategic Options
ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference
ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
Major Government Clinical Study Approved for Anadis' AIDS Therapy
Analyst Reports for Metalico Inc., ADVENTRX Pharmaceuticals Inc., Exeter Resource Corporation and Ener1 Inc.
ADVENTRX Announces Restructuring and Cost Reduction Initiatives
Anadis Commercializing "BioGard" Adjunctive Therapy for HIV & AIDS
Clinical Trial Protocol Against Cancer Therapy Side Effects (Mucositis) Approved
Analyst Reports for IA Global Inc., China Shenghuo Pharmaceutical Holdings Inc., ADVENTRX Pharmaceuticals Inc., And FieldPoint Petroleum Corporation
ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update
ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
Revised Analyst Reports for Gastar Exploration Ltd., ADVENTRX Pharmaceuticals Inc., Pioneer Drilling Company, and Golden Star Resources Ltd.
Anadis' Cancer Related Mucositis Project Awarded with VISTECH Grant
ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
ADVENTRX Settles Dispute With Former Licensee
ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study - May 27 2008 12:55AM
ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference - May 27 2008 1:41AM
ADVENTRX Pharmaceuticals Reports First Quarter 2008 Financial Results - May 27 2008 1:40AM
ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results - Jun 1 2008 6:48AM
ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study
ADVENTRX Appoints Vice President of Manufacturing
ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer